Innovators in comprehensive urological care
Men with advanced prostate cancer (PCa), especially those with castration-resistant prostate cancer (CRPC), have an elevated risk of disease-related complications near the end...
09/11/2022
SUO 2018: Combination Chemotherapy-Immunotherapy for Bladder Cancer Published 30 November 2018 Phoenix, Arizona (UroToday.com) Dr. William Tabayoyong, a Society of Urologic...
09/03/2022
SUO 2018: Bladder Cancer and the Microbiome: Emerging Evidence Published 29 November 2018 Phoenix, Arizona (UroToday.com) Dr. Steinberg presented in his talk the role of the...
08/25/2022
Urine biomarkers for bladder cancer Urine biomarkers for bladder cancer Go to: Home / Urine biomarkers for bladder cancer What is a biomarker? Biomarkers are substances that...
08/25/2022
IN July this year, doctors told Andrew Winterbottom, founder of the Oxfordshire-based charity Fight Bladder Cancer, he had perhaps two years to live. He had been diagnosed with...
08/14/2022
Several recent updates from clinical trials are transforming the treatment landscape for urothelial carcinoma across a variety of subtypes. The use of immunotherapy, in...
08/13/2022
Hypogonadal men who receive testosterone replacement therapy (TRT) may have a lower incidence of prostate cancer (PCa) than those not receiving TRT, according to study findings...
07/19/2022
David Ritchie was diagnosed with Bladder Cancer in 2019 and was left utterly devastated. He had always been extremely healthy and a keen runner. So, after being told what would...
06/14/2022
Know the Facts About Bladder Cancer Know the Facts About Bladder Cancer Published Date May 31, 2022 You likely know that your bladder’s job is to store and release urine,...
06/12/2022
Robot-assisted surgery used to perform bladder cancer removal and reconstruction, enables patients to recover far more quickly and spend significantly (20 per cent) less time in...
06/08/2022
MONDAY, May 16, 2022 (HealthDay News) -- Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor's return,...
06/07/2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer Nature Communications volume 13,...
05/20/2022
